Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management

Background: Circulating tumor DNA (ctDNA) in the blood plasma of cancer patients is an emerging biomarker used across oncology, facilitating noninvasive disease monitoring and genetic profiling at various disease milestones. Digital droplet PCR (ddPCR) technologies have demonstrated high sensitivity...

Descripción completa

Detalles Bibliográficos
Autores principales: Wehrle, Julius, Philipp, Ulrike, Jolic, Martina, Follo, Marie, Hussung, Saskia, Waldeck, Silvia, Deuter, Max, Rassner, Michael, Braune, Jan, Rawluk, Justyna, Greil, Christine, Waller, Cornelius F., Becker, Heiko, Duque-Afonso, Jesús, Illert, Anna L., Fritsch, Ralph M., Meiss, Frank, Duyster, Justus, von Bubnoff, Nikolas, Scherer, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459590/
https://www.ncbi.nlm.nih.gov/pubmed/32748806
http://dx.doi.org/10.3390/diagnostics10080550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459590/
https://www.ncbi.nlm.nih.gov/pubmed/32748806
http://dx.doi.org/10.3390/diagnostics10080550

Ejemplares similares